FOCUS Investment Banking Named #1 Lower Middle Market M&A Advisor In Q2 2023​

2024-02-13T15:06:19+00:00Advanced Manufacturing, Agriculture, Articles, Auto parts and accessories, Automotive Aftermarket, Automotive Dealers, Behavioral Health, Biotech, Blogs, Car Washes, Cardiology, Cloud Services, Collision, Construction, Consumer, Dermatology, Distribution, Downloads, E-commerce, E-Learning, Education & Human Capital Development News, Electronics, Engineering, ENT & Allergy, Entertainment, Environmental Services, Federal Contracting, Financial Services, FOCUS Sale Preparation, Food & Beverage, Gastroenterology, Government and Defense, Healthcare, Home Health & Hospice, Human Capital Management, Industrials and Energy, Managed Service Providers, Mergers & Acquisitions News, Mergers, Acquisitions & Divestitures, Oil and Lube, Paint Jobbers, Supply Chain, Technology Services, Telecom Technologies & Services, Tire and Service|

Washington, DC, (July 27, 2023) – FOCUS Investment Banking (“FOCUS”) ...

Alzheimer’s Disease and the Growing Dementia Epidemic

2024-02-12T22:57:11+00:00Articles, Biotech, Healthcare, Newsletter, Technology Services|

Most of us know someone—relative, friend, or colleague—suffering from dementia, a medical term that describes symptoms of impaired cognition (memory and thinking), behavior, social abilities, and daily functioning. Dementia isn’t a specific disease and can range in severity from mild to severe. It has many different non-reversible and reversible causes.

Middle Market Investment Banking Firm FOCUS LLC Represents the Bioline Group of Companies in its Sale to Meridian Bioscience, Inc. Deal Marks Tenth Deal for FOCUS in 2010

2024-02-12T23:34:11+00:00Biotech, Healthcare, International News, International Transactions, Life Sciences, Mergers & Acquisitions News, Mergers, Acquisitions & Divestitures|

Washington DC (July 23, 2010) – FOCUS LLC, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that the Bioline group of companies has been acquired by Meridian Bioscience, Inc. (NASDAQ: VIVO). FOCUS represented Bioline in this transaction.

Go to Top